INSMED Inc
INSM· Nasdaq
INSMINSMED Inc
Filed May 7, 2026 · 10-Q · 37 days after period end · 0001104506-26-000032
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $305.96M | $92.82M | $75.50M | $65.21M |
| Net Income | -$163.56M | -$256.58M | -$157.09M | -$159.76M |
| EPS Diluted | -$0.76 | -$1.42 | -$1.06 | -$1.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 7, 2026 · 37 d after period end
